FIELD: medicine, parasitology, dermatology. SUBSTANCE: method involves an intraduodenal administration of 0.5% solution of metronidazol (100 ml) in combination with pathogenetic preparations at age doses. Method is used for prevention of skin exacerbation and decrease of by-side effects. EFFECT: enhanced effectiveness of treatment.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF CHRONIC LAMBLIASIS TREATMENT | 2007 |
|
RU2336086C1 |
| METHOD FOR TREATING THE CASES OF FOCAL ALOPECIA IN CHILDREN | 1998 |
|
RU2159638C2 |
| METHOD FOR PROGNOSTICATION OF TENDENCY OF PSORIASIS | 1991 |
|
RU2009509C1 |
| METHOD OF PSORIASIS TREATMENT | 1992 |
|
RU2061483C1 |
| METHOD FOR TREATING RUBROMYCOSIS OF SMOOTH SKIN | 0 |
|
SU1805960A3 |
| METHOD FOR TREATING THE CASES OF NEURODERMITE | 1994 |
|
RU2099061C1 |
| LIPID COMPLEX FOR TREATMENT OF CHRONIC DERMATOSES | 1998 |
|
RU2159118C2 |
| METHOD FOR TREATING ALLERGIES | 2008 |
|
RU2367453C1 |
| METHOD FOR TREATMENT OF ATOPIC DERMATITIS COMPLICATED BY SECONDARY INFECTION | 0 |
|
SU1816215A3 |
| METHOD OF PSORIASIS TREATMENT | 0 |
|
SU1805986A3 |
